Immunogen Inc (DELISTED) (IMGN:DL)
31.23
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
Immunogen Gross Profit Margin (Quarterly): 98.10% for Sept. 30, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 98.10% |
| June 30, 2023 | 98.91% |
| March 31, 2023 | 98.74% |
| December 31, 2022 | 99.57% |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 |
| Date | Value |
|---|---|
| June 30, 2017 | |
| March 31, 2017 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 | |
| March 31, 2011 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
98.10%
Minimum
Sep 2023
99.57%
Maximum
Dec 2022
98.83%
Average
98.83%
Median
Gross Profit Margin (Quarterly) Benchmarks
| AbbVie Inc | 70.87% |
| Pfizer Inc | 70.27% |
| Johnson & Johnson | 69.01% |
| Merck & Co Inc | 75.51% |
| Cerevel Therapeutics Holdings Inc (DELISTED) | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -24.37% |
| Return on Assets | -14.52% |
| Return on Invested Capital | -22.25% |
| Profit Margin (Quarterly) | 27.11% |
| Operating Margin (Quarterly) | 22.88% |
| Return on Net Operating Assets | -105.4% |